TMPRSS11D and acute myeloid leukemia: In correlation analysis, HAT‐L4 expression in AML bone marrow cells correlated with minimal residual disease (MRD) and poor prognostic risks, but not the gender, age or AML subtype in the posttreatment patients (Table S2).